Emerging curative-intent minimally-invasive therapies for hepatocellular carcinoma.

Autor:	Zane KE; College of Medicine, The Ohio State University, Columbus, OH 43210, United States., Nagib PB; College of Medicine, The Ohio State University, Columbus, OH 43210, United States., Jalil S; Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, United States., Mumtaz K; Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, United States., Makary MS; Division of Vascular and Interventional Radiology, Department of Radiology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, United States. mina.makary@osumc.edu.
Jazyk:	angličtina
Zdroj:	World journal of hepatology [World J Hepatol] 2022 May 27; Vol. 14 (5), pp. 885-895.
DOI:	10.4254/wjh.v14.i5.885
Abstrakt:	Hepatocellular carcinoma (HCC) is the most common cause of liver malignancy and the fourth leading cause of cancer deaths universally. Cure can be achieved for early stage HCC, which is defined as 3 or fewer lesions less than or equal to 3 cm in the setting of Child-Pugh A or B and an ECOG of 0. Patients outside of these criteria who can be down-staged with loco-regional therapies to resection or liver transplantation (LT) also achieve curative outcomes. Traditionally, surgical resection, LT, and ablation are considered curative therapies for early HCC. However, results from recently conducted LEGACY study and DOSISPHERE trial demonstrate that transarterial radio-embolization has curative outcomes for early HCC, leading to its recent incorporation into the Barcelona clinic liver criteria guidelines for early HCC. This review is based on current evidence for curative-intent loco-regional therapies including radioembolization for early-stage HCC. Competing Interests: Conflict-of-interest statement: The authors declare they have no conflicts of interest (©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu